Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
724 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
- Where
- Nanjing
- Életkor
- 75 év and over
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06555471 - No phaseTaking peoplePreliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
- Where
- Changsha
- Életkor
- 18 év to 90 év
- People
- 30
- Run by
- Hunan Cancer Hospital
See details and how to joinNCT06543108 - No phaseTaking peopleDevelopment and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph Node Metastasis
- Where
- Shijiazhuang
- Életkor
- 18 év and over
- People
- 300
- Run by
- Hebei Medical University
See details and how to joinNCT06534814 - 2. fázisNot yet taking people in KínaSurufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- RenJi Hospital
See details and how to joinNCT06531291 - No phaseTaking peopleGoal-directed Enteral Nutritional Perioperative Management
- Where
- Anyang, Beijing, Changzhi, Chongqing, Fuzhou, Huai'an, Jinan, Kunming, Nanjing, Shanghai, Taiyuan, Tianjin, Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 400
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06510543 - No phaseTaking peopleConstruction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology
- Where
- Shijiazhuang
- Életkor
- 18 év and over
- People
- 30 000
- Run by
- Qun Zhao
See details and how to joinNCT06506825 - 2. fázisTaking peoplePPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT06354140 - 3. fázisTaking peoplePD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 436
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06086457 - 2. fázisTaking peopleAdjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 146
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06272214 - 2. fázisTaking peopleSintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
- Where
- Hangzhou
- Életkor
- 70 év to 85 év
- People
- 191
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06413342 - 4. fázisNot yet taking people in KínaClinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
- Where
- Xi'an
- Életkor
- 18 év and over
- People
- 44
- Run by
- First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT06499610 - No phaseNot yet taking people in KínaA Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 300
- Run by
- Wuhan University
See details and how to joinNCT06496919 - No phaseNot yet taking people in KínaProspective Observational Cohort Study
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 1326
- Run by
- Lin Chen
See details and how to joinNCT06493448 - 2. fázisNot yet taking people in KínaRC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 20
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06492317 - 3. fázisTaking peopleMetronomic Capecitabine in Stage III Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 722
- Run by
- Fudan University
See details and how to joinNCT06313567 - 2. fázisTaking peopleShort Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 28
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06487429 - 2. fázisNot yet taking people in KínaA Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 70
- Run by
- Rui-hua Xu, MD, PhD
See details and how to joinNCT06487702 - 3. fázisTaking peopleAn Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 356
- Run by
- Ruijin Hospital
See details and how to joinNCT06339060 - 2. fázisTaking peopleNeoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
- Where
- Shanghai
- Életkor
- 76 év and over
- People
- 60
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06385730 - 2. fázisNot yet taking people in KínaNeoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 34
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06469060 - 2. fázisTaking peoplePerioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 26
- Run by
- Ruijin Hospital
See details and how to joinNCT06482788 - 2. fázisTaking peopleAK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
- Where
- Harbin
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Harbin Medical University
See details and how to joinNCT06196697 - 1/2. fázisTaking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - 4. fázisNot yet taking people in KínaEffect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients
- Where
- Qingdao, Wuhan
- Életkor
- 18 év to 75 év
- People
- 702
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT05498766 - 3. fázisTaking people3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 702
- Run by
- Fujian Medical University
See details and how to joinNCT06161207